ORCID as entered in ROS

Select Publications
2025, 'Global Trends in Analgesic Opioid Use in Pregnancy: A Retrospective Cohort Study', Anesthesiology, 142, pp. 1100 - 1113, http://dx.doi.org/10.1097/ALN.0000000000005418
,2024, 'Opioid analgesic exposure during the first trimester of pregnancy and the risk of major congenital malformations in infants: a systematic review and meta-analysis†', Anaesthesia, 79, pp. 967 - 977, http://dx.doi.org/10.1111/anae.16307
,2024, 'Prevalence and Persistence of Prescription Opioid Use Following Hospital Discharge after Childbirth: An Australian Population-Based Cohort Study', Anesthesia and Analgesia, 138, pp. 970 - 979, http://dx.doi.org/10.1213/ANE.0000000000006582
,2024, 'The burden of prenatal and early life maternal substance use among children at risk of maltreatment: A systematic review', Drug and Alcohol Review, 43, pp. 823 - 847, http://dx.doi.org/10.1111/dar.13835
,2024, 'Data Resource Profile: The Early Life Course data platform for research on perinatal and early childhood exposures and outcomes in Australia', International Journal of Epidemiology, 53, http://dx.doi.org/10.1093/ije/dyae045
,2024, 'Medicine utilization studies in Australian individual-level dispensing data: A blinded, multi-center replicated analysis', Pharmacoepidemiology and Drug Safety, 33, http://dx.doi.org/10.1002/pds.5776
,2024, 'Prevalence and Persistence of Prescription Opioid Use Following Hospital Discharge After Childbirth: An Australian Population-Based Cohort Study', Obstetric Anesthesia Digest, 44, pp. 236 - 237, http://dx.doi.org/10.1097/01.aoa.0001080308.34895.4e
,2022, 'G protein–coupled receptor kinase 5 regulates thrombin signaling in platelets via PAR-1', Blood Advances, 6, pp. 2319 - 2330, http://dx.doi.org/10.1182/bloodadvances.2021005453
,2022, 'Prescription opioid use in Australian women of reproductive age: Implications for unplanned pregnancies', British Journal of Clinical Pharmacology, 88, pp. 1298 - 1320, http://dx.doi.org/10.1111/bcp.15074
,2022, 'Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover', CANCER & METABOLISM, 10, http://dx.doi.org/10.1186/s40170-021-00278-1
,2020, 'Insulin signaling requires glucose to promote lipid anabolism in adipocytes', Journal of Biological Chemistry, 295, pp. 13250 - 13266, http://dx.doi.org/10.1074/jbc.ra120.014907
,2019, 'Extracellular fatty acids are the major contributor to lipid synthesis in prostate cancer', Molecular Cancer Research, 17, pp. 949 - 962, http://dx.doi.org/10.1158/1541-7786.MCR-18-0347
,2018, 'Heterogeneity of fatty acid metabolism in breast cancer cells underlies differential sensitivity to palmitate-induced apoptosis', Molecular Oncology, 12, pp. 1623 - 1638, http://dx.doi.org/10.1002/1878-0261.12368
,2018, 'Detection of the Cyanotoxins L-BMAA Uptake and Accumulation in Primary Neurons and Astrocytes', Neurotoxicity Research, 33, pp. 55 - 61, http://dx.doi.org/10.1007/s12640-017-9787-9
,2017, 'Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases', Neuropharmacology, 112, pp. 373 - 388, http://dx.doi.org/10.1016/j.neuropharm.2016.03.024
,2016, 'Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis', Frontiers in Immunology, 7, pp. 246, http://dx.doi.org/10.3389/fimmu.2016.00246
,2015, 'Expression of the kynurenine pathway in human peripheral blood mononuclear cells: Implications for inflammatory and neurodegenerative disease', Plos One, 10, pp. e0131389, http://dx.doi.org/10.1371/journal.pone.0131389
,2021, 'Prescription opioid use in Australian women of reproductive age from 2013 to 2020', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 308 - 309, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300627&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2024, 'Retention in opioid agonist treatment following childbirth and associated factors', Wesley Conference Centre, Sydney NSW, presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024
,2024, 'Retention in opioid agonist treatment following childbirth and associated factors', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=97s
,2024, 'Trends in the use of opioid agonist treatment for opioid dependence in pregnancy', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=1850s
,2024, 'Use of opioid agonist therapy in pregnancy: Timing of initiation and treatment retention', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=2664s
,2017, 'Laquinimod as a regulator of Kynurenine Pathway in Multiple Sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, Vol. 23, pp. NP27 - NP27, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,